World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
31352
World Ranking
11731
National Ranking
436

Silvio Garattini publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Silvio Garattini sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 974 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Silvio Garattini D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Silvio Garattini sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 1992 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Silvio Garattini is affiliated with the Mario Negri Institute for Pharmacological Research in Italy. Their research output is primarily situated within the field of Medicine, with a total of 69 publications. Garattini's work spans various subfields including Economics and Econometrics, Infectious Diseases, Pulmonary and Respiratory Medicine, Neurology, and Emergency Medicine.

The scientist's recent contributions include the following papers:

  • The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines, 2021, Nature Nanotechnology
  • Switching Among Biosimilars: A Review of Clinical Evidence, 2022, Frontiers in Pharmacology
  • Surface plasmon resonance unveils important pitfalls of enzyme-linked immunoassay for the detection of anti-infliximab antibodies in patients' sera, 2021, Scientific Reports
  • Effectiveness, Tolerability and Prescribing Choice of Antiviral Molecules Molnupiravir, Remdesivir and Nirmatrelvir/r: A Real-World Comparison in the First Ten Months of Use, 2023, Viruses
  • Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial, 2021, European Journal of Cancer

Garattini frequently publishes in several venues, notably:

  • European Journal of Clinical Pharmacology
  • PubMed
  • Frontiers in Pharmacology
  • Viruses
  • Università degli Studi di Trento

Their work extensively covers topics such as Health Systems, Economic Evaluations, Quality of Life; Pharmaceutical Economics and Policy; COVID-19 Clinical Research Studies; Pharmaceutical studies and practices; SARS-CoV-2 and COVID-19 Research; Long-Term Effects of COVID-19; and Gastric Cancer Management and Outcomes.

Garattini has collaborated often with the following researchers:

  • Cosmo Del Borgo
  • Anna Carraro
  • Miriam Lichtner
  • Rita Banzi
  • Raffaella Marocco

Among recognitions, Garattini was named a Fellow of the American Association for the Advancement of Science (AAAS) in 1992.

Best Publications

  • How to increase value and reduce waste when research priorities are set

    Iain Chalmers;Michael B Bracken;Ben Djulbegovic;Silvio Garattini

  • Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus

    Maria Grazia De Simoni;Carlo Perego;Teresa Ravizza;Daniela Moneta

  • Prognosis of untreated patients with idiopathic membranous nephropathy

    Arrigo Schieppati;Lidia Mosconi;Annalisa Perna;Giuliano Mecca

  • Caffeine disposition after oral doses

    Maurizio Bonati;Maurizio Bonati;Roberto Latini;Roberto Latini;Ferruccio Galletti;Ferruccio Galletti;John F Young;John F Young

  • Clinical pharmacokinetics of diazepam.

    Marinella Mandelli;Gianni Tognoni;Silvio Garattini

  • Studies on behavioral and biochemical changes in rats after lesion of midbrain raphé

    W. Kostowski;E. Giacalone;S. Garattini;L. Valzelli

  • The mechanism of action of fenfluramine.

    S Garattini;W Buczko;A Jori;R Samanin

  • Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.

    Jakub Adamski;Brian Godman;Brian Godman;Brian Godman;Gabriella Ofierska-Sujkowska;Bogusława Osińska

  • Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium.

    Alessandro Nobili;Silvio Garattini;Pier Mannuccio Mannucci

  • m-Chlorophenylpiperazine: A central serotonin agonist causing powerful anorexia in rats

    R. Samanin;T. Mennini;A. Ferraris;C. Bendotti

  • Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat

    S. Caccia;M. Cappi;C. Fracasso;S. Garattini

  • Tianeptine, a selective enhancer of serotonin uptake in rat brain.

    T. Mennini;E. Mocaer;S. Garattini

  • Non-inferiority trials are unethical because they disregard patients' interests.

    Silvio Garattini;Vittorio Bertele

  • Biochemical pharmacology of the anorectic drug fenfluramine: a review

    S. Garattini;S. Cactia;T. Mennini;R. Samanin

  • Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system

    S. Garattini;T. Mennini;C. Bendotti;R. Invernizzi

  • Interspecies Comparison of In Vivo Caffeine Pharmacokinetics in Man, Monkey, Rabbit, Rat and Mouse

    M. Bonati;R. Latini;G. Tognoni;J. F. Young

  • The effects of selective lesioning of brain serotonin or catecholamine containing neurones on the anorectic activity of fenfluramine and amphetamine.

    R. Samanin;D. Ghezzi;L. Valzelli;S. Garattini

  • Effects of new smoking regulations in Italy

    S. Gallus;P. Zuccaro;P. Colombo;G. Apolone

  • Immunosuppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in strains of mice with different susceptibility to induction of aryl hydrocarbon hydroxylase

    Annunciata Vecchi;Marina Sironi;Maria Antonia Canegrati;Martino Recchia

  • Why rare diseases are an important medical and social issue. Commentary

    Giuseppe Remuzzi;Silvio Garattini;Arrigo Schieppati;Jan-Inge Henter

Frequent Co-Authors

Rosario Samanin
Rosario Samanin Mario Negri Institute for Pharmacological Research
Mario Salmona
Mario Salmona Mario Negri Institute for Pharmacological Research
Roberto Fanelli
Roberto Fanelli Mario Negri Institute for Pharmacological Research
Giuseppe Remuzzi
Giuseppe Remuzzi Mario Negri Institute for Pharmacological Research
Corrado Barbui
Corrado Barbui University of Verona
Carlo La Vecchia
Carlo La Vecchia University of Milan
Maurizio D'Incalci
Maurizio D'Incalci Humanitas University
Alberto Mantovani
Alberto Mantovani Humanitas University
Gianni Tognoni
Gianni Tognoni University of Milan
Sergio Bernasconi
Sergio Bernasconi University of Parma

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens up a variety of promising career options, both in clinical and administrative roles. Many students choose to pursue related online degrees that offer flexibility and fast-tracked options for professional growth.

For those interested in leadership or management positions, consider exploring cahme accredited online healthcare administration programs. These programs prepare you for executive roles in hospitals, clinics, and other medical organizations.

Registered nurses can advance their education through an rn to bsn without clinicals program, providing a convenient pathway to higher qualifications and increased responsibilities—often without the need for in-person clinical hours.

Nurses seeking advanced practice roles might consider the fastest msn to dnp program, allowing for a rapid transition into leadership, education, or specialized clinical practice.

If balancing work and study is key, you may also be interested in a dnp program without clinical hours. These programs are designed for working professionals who want to attain the highest level of nursing education with a more flexible approach.

Best Scientists Citing Silvio Garattini

Trending Scientists

Recently Published Articles